[ET Net News Agency, 9 July 2026] HANSOH PHARMA (03692) fell 2.8% to HK$31.22.
It hits an intra-day low of HK$31.14, and an intra-day high of HK$32.14. The total shares traded was 8.34 million, with a value of HK$263.51m. The active buy/sell ratio is 55:45, with net buying turnover of HK$22.59m. MERRILL LYNCH FE accounts for greatest net responsive buying turnover of HK$10.25m, with volume weighted average price of HK$31.679. INSTINET PACIFIC accounts for greatest net responsive selling turnover of HK$12.89m, with volume weighted average price of HK$31.609. The stock has fallen a combined 8.1% over the past 3 consecutive trading days.
The Hang Seng Index now fell 219 points, or 0.9% to 23,979; the Hang Seng China Enterprises Index now fell 89 points, or 1.1% to 7,994.
Basic Information| Nominal | 31.220 | % Chg | -2.80% |
| High | 32.140 | Low | 31.140 |
| Shares Tr | 8.34m | Turnover | 263.51m |
| 10-D SMA | 31.138 | %H.V | 46.488 |
| 20-D SMA | 30.271 | VWAP | 31.603 |
| 50-D SMA | 32.478 | RSI14 | 50.082 |
Status: Active buy/sell ratio is 55:45, with net buying turnover of HK$22.59m, falling a combined 8.1% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 31.22 | -2.80 |
| SIHUAN PHARM (00460) | 0.83 | -4.60 |
| GRAND PHARMA (00512) | 5.10 | -0.97 |
| SBP GROUP (01177) | 5.00 | +3.73 |
| HENGRUI PHARMA (01276) | 58.60 | -0.85 |
| LIVZON PHARMA (01513) | 25.30 | -2.54 |
| LUYE PHARMA (02186) | 1.91 | -2.05 |
| FOSUN PHARMA (02196) | 15.89 | -2.58 |
| SH PHARMA (02607) | 11.73 | -1.10 |
| CHINARES PHARMA (03320) | 4.48 | -1.10 |
(ed)
